Revel Pharmaceuticals
UEI: RBFMLGKG8KZ3
• CAGE: 8GJQ4
Overview
Awardee Type
Parent
Name
Revel Pharmaceuticals
Headquarters
San Francisco, CA
United States
United States
Most Recent Award
Aug. 1, 2025
Calculating
Federal grant recipient
REVEL PHARMACEUTICALS INC.
dba REVEL PHARMACEUTICALS INC
(UEI RBFMLGKG8KZ3, CAGE 8GJQ4)
is headquartered in San Francisco CA.
The corporation
was founded in July 2019 and
federally registered in
October 2019.
Federal Award Analysis
Revel Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
REVEL PHARMACEUTICALS INC.
DBA
REVEL PHARMACEUTICALS INC
Division Name
REVEL PHARMACEUTICALS
UEI
RBFMLGKG8KZ3
CAGE Code
8GJQ4
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
July 8, 2019
Initial Registration
Oct. 22, 2019
Last Registration
Jan. 26, 2026
Registration Activation
Jan. 23, 2026
Registration Expiration
Jan. 21, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No